APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neurovascular Devices

Neurovascular Devices refer to the tools that used to pass through the blood vessels to diagnose and treat diseases and conditions of the brain and nervous system rather than using open surgery. Neurovascular Devices comprise a large segment of medical devices, including embolic coils, neurovascular stents (carotid and intracranial stents), intravascular devices, neurothrombectomy devices, flow diverters, embolic protection device, balloons and stent retrievers.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Neurovascular Devices refer to the tools that used to pass through the blood vessels to diagnose and treat diseases and conditions of the brain and nervous system rather than using open surgery. Neurovascular Devices comprise a large segment of medical devices, including embolic coils, neurovascular stents (carotid and intracranial stents), intravascular devices, neurothrombectomy devices, flow diverters, embolic protection device, balloons and stent retrievers.

Selected research

Market Outlook & Growth Opportunities

Global Neurovascular Devices Market Outlook and Growth Opportunities 2026

1 January 2026198 pages

Choose your research edition.

Industry ResearchNeurovascular Devices Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurovascular Devices Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Neurovascular Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurovascular Devices Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurovascular Devices Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Neurovascular Devices refer to the tools that used to pass through the blood vessels to diagnose and treat diseases and conditions of the brain and nervous system rather than using open surgery. Neurovascular Devices comprise a large segment of medical devices, including embolic coils, neurovascular stents (carotid and intracranial stents), intravascular devices, neurothrombectomy devices, flow diverters, embolic protection device, balloons and stent retrievers.

Top players in the neurovascular devices market are Stryker Corporation and Medtronic, Johnson & Johnson, Terumo Corporation, Penumbra, Abbott Laboratories, W. L. Gore & Associates, Microport Scientific Corporation and some others are also key players in this field.

Geographically, the neurovascular devices market is classified into North America, Europe, Japan, China and The Rest. North America dominates the global market, followed by Europe and Japan.

Read the full market overview

On the basis of product, the neurovascular devices market is classified into four major segments—aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems, support devices, and neurothrombectomy devices. The aneurysm coiling and embolization devices segment is the largest and accounts for about 37% of the global neurovascular devices market.

Neurovascular devices are widely used in hospitals, clinics and ambulatory surgical units.

This report provides an overview of the global Neurovascular Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neurovascular Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neurovascular Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Neurovascular Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Neurovascular Devices Segment by Company

Stryker Corporation

Johnson & Johnson

Medtronic

Terumo

Penumbra

Microport Scientific Corporation

Abbott Vascular

W. L. Gore & Associates

Neurovascular Devices Segment by Type

Aneurysm Coiling & Embolization Devices

Cerebral Balloon Angioplasty & Stenting Systems

Support Devices

Neurothrombectomy Devices

Neurovascular Devices Segment by Application

Hospitals

Clinics

Ambulatory Surgical Units

Neurovascular Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Neurovascular Devices status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Neurovascular Devices market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Neurovascular Devices significant trends, drivers, influence factors in global and regions.

6. To analyze Neurovascular Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurovascular Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurovascular Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurovascular Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Neurovascular Devices market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neurovascular Devices industry.

Chapter 3: Detailed analysis of Neurovascular Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Neurovascular Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Neurovascular Devices in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Neurovascular Devices Industry Trends Table 2. Neurovascular Devices Industry Drivers Table 3. Neurovascular Devices Industry Opportunities and Challenges Table 4. Neurovascular Devices Industry Restraints Table 5. Global Neurovascular Devices Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Neurovascular Devices Revenue Share by Company (2021-2026) Table 7. Global Neurovascular Devices Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Neurovascular Devices Sales Volume Share by Company (2021-2026) Table 9. Global Neurovascular Devices Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Neurovascular Devices Company Ranking, (2024-2026) & (USD Million) Table 11. Global Neurovascular Devices Key Company Manufacturing Base & Headquarters Table 12. Global Neurovascular Devices Company, Product Type & Application Table 13. Global Neurovascular Devices Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Neurovascular Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Aneurysm Coiling & Embolization Devices Table 18. Significant Companies of Cerebral Balloon Angioplasty & Stenting Systems Table 19. Significant Companies of Support Devices Table 20. Significant Companies of Neurothrombectomy Devices Table 21. Global Neurovascular Devices Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Neurovascular Devices Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Neurovascular Devices Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Neurovascular Devices Sales Volume Share by Type (2021-2026) Table 25. Global Neurovascular Devices Sales Volume Share by Type (2027-2032) Table 26. Global Neurovascular Devices Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Neurovascular Devices Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Neurovascular Devices Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Neurovascular Devices Sales Value Share by Type (2021-2026) Table 30. Global Neurovascular Devices Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospitals Table 32. Significant Companies of Clinics Table 33. Significant Companies of Ambulatory Surgical Units Table 34. Global Neurovascular Devices Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Neurovascular Devices Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Neurovascular Devices Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Neurovascular Devices Sales Volume Share by Application (2021-2026) Table 38. Global Neurovascular Devices Sales Volume Share by Application (2027-2032) Table 39. Global Neurovascular Devices Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Neurovascular Devices Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Neurovascular Devices Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Neurovascular Devices Sales Value Share by Application (2021-2026) Table 43. Global Neurovascular Devices Sales Value Share by Application (2027-2032) Table 44. Global Neurovascular Devices Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Neurovascular Devices Sales by Region (2021-2026) & (K Units) Table 46. Global Neurovascular Devices Sales Market Share by Region (2021-2026) Table 47. Global Neurovascular Devices Sales by Region (2027-2032) & (K Units) Table 48. Global Neurovascular Devices Sales Market Share by Region (2027-2032) Table 49. Global Neurovascular Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Neurovascular Devices Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Neurovascular Devices Sales Value Share by Region (2021-2026) Table 52. Global Neurovascular Devices Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Neurovascular Devices Sales Value Share by Region (2027-2032) Table 54. Global Neurovascular Devices Market Average Price (USD/Unit) by Region (2021-2026) Table 55. Global Neurovascular Devices Market Average Price (USD/Unit) by Region (2027-2032) Table 56. Global Neurovascular Devices Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Neurovascular Devices Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Neurovascular Devices Sales by Country (2021-2026) & (K Units) Table 59. Global Neurovascular Devices Sales Market Share by Country (2021-2026) Table 60. Global Neurovascular Devices Sales by Country (2027-2032) & (K Units) Table 61. Global Neurovascular Devices Sales Market Share by Country (2027-2032) Table 62. Global Neurovascular Devices Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Neurovascular Devices Sales Value Market Share by Country (2021-2026) Table 64. Global Neurovascular Devices Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Neurovascular Devices Sales Value Market Share by Country (2027-2032) Table 66. Stryker Corporation Company Information Table 67. Stryker Corporation Business Overview Table 68. Stryker Corporation Neurovascular Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 69. Stryker Corporation Neurovascular Devices Product Portfolio Table 70. Stryker Corporation Recent Development Table 71. Johnson & Johnson Company Information Table 72. Johnson & Johnson Business Overview Table 73. Johnson & Johnson Neurovascular Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Johnson & Johnson Neurovascular Devices Product Portfolio Table 75. Johnson & Johnson Recent Development Table 76. Medtronic Company Information Table 77. Medtronic Business Overview Table 78. Medtronic Neurovascular Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Medtronic Neurovascular Devices Product Portfolio Table 80. Medtronic Recent Development Table 81. Terumo Company Information Table 82. Terumo Business Overview Table 83. Terumo Neurovascular Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Terumo Neurovascular Devices Product Portfolio Table 85. Terumo Recent Development Table 86. Penumbra Company Information Table 87. Penumbra Business Overview Table 88. Penumbra Neurovascular Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Penumbra Neurovascular Devices Product Portfolio Table 90. Penumbra Recent Development Table 91. Microport Scientific Corporation Company Information Table 92. Microport Scientific Corporation Business Overview Table 93. Microport Scientific Corporation Neurovascular Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Microport Scientific Corporation Neurovascular Devices Product Portfolio Table 95. Microport Scientific Corporation Recent Development Table 96. Abbott Vascular Company Information Table 97. Abbott Vascular Business Overview Table 98. Abbott Vascular Neurovascular Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Abbott Vascular Neurovascular Devices Product Portfolio Table 100. Abbott Vascular Recent Development Table 101. W. L. Gore & Associates Company Information Table 102. W. L. Gore & Associates Business Overview Table 103. W. L. Gore & Associates Neurovascular Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. W. L. Gore & Associates Neurovascular Devices Product Portfolio Table 105. W. L. Gore & Associates Recent Development Table 106. Key Raw Materials Table 107. Raw Materials Key Suppliers Table 108. Neurovascular Devices Distributors List Table 109. Neurovascular Devices Customers List Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Neurovascular Devices Product Image Figure 2. Global Neurovascular Devices Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurovascular Devices Sales Value (2021-2032) & (US$ Million) Figure 4. Global Neurovascular Devices Sales (2021-2032) & (K Units) Figure 5. Global Neurovascular Devices Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Neurovascular Devices Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Aneurysm Coiling & Embolization Devices Image Figure 10. Cerebral Balloon Angioplasty & Stenting Systems Image Figure 11. Support Devices Image Figure 12. Neurothrombectomy Devices Image Figure 13. Global Neurovascular Devices Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Neurovascular Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Neurovascular Devices Sales Volume Share by Type (2021-2032) Figure 16. Global Neurovascular Devices Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Neurovascular Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Neurovascular Devices Sales Value Share by Type (2021-2032) Figure 19. Hospitals Image Figure 20. Clinics Image Figure 21. Ambulatory Surgical Units Image Figure 22. Global Neurovascular Devices Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Neurovascular Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Neurovascular Devices Sales Volume Share by Application (2021-2032) Figure 25. Global Neurovascular Devices Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Neurovascular Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Neurovascular Devices Sales Value Share by Application (2021-2032) Figure 28. Global Neurovascular Devices Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Neurovascular Devices Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Neurovascular Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Neurovascular Devices Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Neurovascular Devices Sales Value (2021-2032) & (US$ Million) Figure 33. North America Neurovascular Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Neurovascular Devices Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Neurovascular Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Neurovascular Devices Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Neurovascular Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Neurovascular Devices Sales Value (2021-2032) & (US$ Million) Figure 39. South America Neurovascular Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Neurovascular Devices Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Neurovascular Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Neurovascular Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Neurovascular Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Neurovascular Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Neurovascular Devices Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Neurovascular Devices Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Aneurysm Coiling & Embolization Devices
  • Cerebral Balloon Angioplasty & Stenting Systems
  • Support Devices
  • Neurothrombectomy Devices
Applications
  • Hospitals
  • Clinics
  • Ambulatory Surgical Units
Companies covered
  • Stryker Corporation
  • Johnson & Johnson
  • Medtronic
  • Terumo
  • Penumbra
  • Microport Scientific Corporation
  • Abbott Vascular
  • W. L. Gore & Associates

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Neurovascular Devices Sales Value (2021-2032)
  4. 1.2.2 Global Neurovascular Devices Sales Volume (2021-2032)
  5. 1.2.3 Global Neurovascular Devices Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Neurovascular Devices Market Dynamics
  1. 2.1 Neurovascular Devices Industry Trends
  2. 2.2 Neurovascular Devices Industry Drivers
  3. 2.3 Neurovascular Devices Industry Opportunities and Challenges
  4. 2.4 Neurovascular Devices Industry Restraints
3 Neurovascular Devices Market by Company
  1. 3.1 Global Neurovascular Devices Company Revenue Ranking in 2025
  2. 3.2 Global Neurovascular Devices Revenue by Company (2021-2026)
  3. 3.3 Global Neurovascular Devices Sales Volume by Company (2021-2026)
  4. 3.4 Global Neurovascular Devices Average Price by Company (2021-2026)
  5. 3.5 Global Neurovascular Devices Company Ranking (2024-2026)
  6. 3.6 Global Neurovascular Devices Company Manufacturing Base and Headquarters
  7. 3.7 Global Neurovascular Devices Company Product Type and Application
  8. 3.8 Global Neurovascular Devices Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Neurovascular Devices Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Neurovascular Devices Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Neurovascular Devices Market by Type
  1. 4.1 Neurovascular Devices Type Introduction
  2. 4.1.1 Aneurysm Coiling & Embolization Devices
  3. 4.1.2 Cerebral Balloon Angioplasty & Stenting Systems
  4. 4.1.3 Support Devices
  5. 4.1.4 Neurothrombectomy Devices
  6. 4.2 Global Neurovascular Devices Sales Volume by Type
  7. 4.2.1 Global Neurovascular Devices Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Neurovascular Devices Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Neurovascular Devices Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Neurovascular Devices Sales Value by Type
  11. 4.3.1 Global Neurovascular Devices Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Neurovascular Devices Sales Value by Type (2021-2032)
  13. 4.3.3 Global Neurovascular Devices Sales Value Share by Type (2021-2032)
5 Neurovascular Devices Market by Application
  1. 5.1 Neurovascular Devices Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Ambulatory Surgical Units
  5. 5.2 Global Neurovascular Devices Sales Volume by Application
  6. 5.2.1 Global Neurovascular Devices Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Neurovascular Devices Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Neurovascular Devices Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Neurovascular Devices Sales Value by Application
  10. 5.3.1 Global Neurovascular Devices Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Neurovascular Devices Sales Value by Application (2021-2032)
  12. 5.3.3 Global Neurovascular Devices Sales Value Share by Application (2021-2032)
6 Neurovascular Devices Regional Sales and Value Analysis
  1. 6.1 Global Neurovascular Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neurovascular Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Neurovascular Devices Sales by Region: 2021-2026
  4. 6.2.2 Global Neurovascular Devices Sales by Region (2027-2032)
  5. 6.3 Global Neurovascular Devices Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Neurovascular Devices Sales Value by Region (2021-2032)
  7. 6.4.1 Global Neurovascular Devices Sales Value by Region: 2021-2026
  8. 6.4.2 Global Neurovascular Devices Sales Value by Region (2027-2032)
  9. 6.5 Global Neurovascular Devices Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Neurovascular Devices Sales Value (2021-2032)
  12. 6.6.2 North America Neurovascular Devices Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Neurovascular Devices Sales Value (2021-2032)
  15. 6.7.2 Europe Neurovascular Devices Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Neurovascular Devices Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Neurovascular Devices Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Neurovascular Devices Sales Value (2021-2032)
  21. 6.9.2 South America Neurovascular Devices Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Neurovascular Devices Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Neurovascular Devices Sales Value Share by Country, 2025 VS 2032
7 Neurovascular Devices Country-level Sales and Value Analysis
  1. 7.1 Global Neurovascular Devices Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Neurovascular Devices Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Neurovascular Devices Sales by Country (2021-2032)
  4. 7.3.1 Global Neurovascular Devices Sales by Country (2021-2026)
  5. 7.3.2 Global Neurovascular Devices Sales by Country (2027-2032)
  6. 7.4 Global Neurovascular Devices Sales Value by Country (2021-2032)
  7. 7.4.1 Global Neurovascular Devices Sales Value by Country (2021-2026)
  8. 7.4.2 Global Neurovascular Devices Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Neurovascular Devices Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Neurovascular Devices Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Neurovascular Devices Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Neurovascular Devices Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Neurovascular Devices Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Neurovascular Devices Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Neurovascular Devices Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Neurovascular Devices Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Neurovascular Devices Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Neurovascular Devices Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Neurovascular Devices Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Neurovascular Devices Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Neurovascular Devices Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Neurovascular Devices Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Neurovascular Devices Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Neurovascular Devices Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Neurovascular Devices Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Neurovascular Devices Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Neurovascular Devices Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Neurovascular Devices Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Neurovascular Devices Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Neurovascular Devices Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Neurovascular Devices Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Neurovascular Devices Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Neurovascular Devices Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Neurovascular Devices Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Neurovascular Devices Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Neurovascular Devices Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Neurovascular Devices Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Neurovascular Devices Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Stryker Corporation
  2. 8.1.1 Stryker Corporation Company Information
  3. 8.1.2 Stryker Corporation Business Overview
  4. 8.1.3 Stryker Corporation Neurovascular Devices Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Stryker Corporation Neurovascular Devices Product Portfolio
  6. 8.1.5 Stryker Corporation Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Neurovascular Devices Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Neurovascular Devices Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Medtronic
  14. 8.3.1 Medtronic Company Information
  15. 8.3.2 Medtronic Business Overview
  16. 8.3.3 Medtronic Neurovascular Devices Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Medtronic Neurovascular Devices Product Portfolio
  18. 8.3.5 Medtronic Recent Developments
  19. 8.4 Terumo
  20. 8.4.1 Terumo Company Information
  21. 8.4.2 Terumo Business Overview
  22. 8.4.3 Terumo Neurovascular Devices Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Terumo Neurovascular Devices Product Portfolio
  24. 8.4.5 Terumo Recent Developments
  25. 8.5 Penumbra
  26. 8.5.1 Penumbra Company Information
  27. 8.5.2 Penumbra Business Overview
  28. 8.5.3 Penumbra Neurovascular Devices Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Penumbra Neurovascular Devices Product Portfolio
  30. 8.5.5 Penumbra Recent Developments
  31. 8.6 Microport Scientific Corporation
  32. 8.6.1 Microport Scientific Corporation Company Information
  33. 8.6.2 Microport Scientific Corporation Business Overview
  34. 8.6.3 Microport Scientific Corporation Neurovascular Devices Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Microport Scientific Corporation Neurovascular Devices Product Portfolio
  36. 8.6.5 Microport Scientific Corporation Recent Developments
  37. 8.7 Abbott Vascular
  38. 8.7.1 Abbott Vascular Company Information
  39. 8.7.2 Abbott Vascular Business Overview
  40. 8.7.3 Abbott Vascular Neurovascular Devices Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Abbott Vascular Neurovascular Devices Product Portfolio
  42. 8.7.5 Abbott Vascular Recent Developments
  43. 8.8 W. L. Gore & Associates
  44. 8.8.1 W. L. Gore & Associates Company Information
  45. 8.8.2 W. L. Gore & Associates Business Overview
  46. 8.8.3 W. L. Gore & Associates Neurovascular Devices Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 W. L. Gore & Associates Neurovascular Devices Product Portfolio
  48. 8.8.5 W. L. Gore & Associates Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Neurovascular Devices Value Chain Analysis
  2. 9.1.1 Neurovascular Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Neurovascular Devices Sales Mode & Process
  6. 9.2 Neurovascular Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Neurovascular Devices Distributors
  9. 9.2.3 Neurovascular Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst